---
layout: post
title: "Notice of Product Exclusion Extensions: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation"
date: 2026-02-05 18:59:23 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-11884
original_published: 2022-06-03 00:00:00 +0000
significance: 8.00
---

# Notice of Product Exclusion Extensions: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** June 03, 2022 00:00 UTC
**Document Number:** 2022-11884

## Summary

In prior notices, the U.S. Trade Representative modified the action in the Section 301 investigation of China's acts, policies, and practices related to technology transfer, intellectual property, and innovation by excluding from additional duties certain medical-care products needed to address the COVID-19 pandemic. Exclusions for medical care products to address COVID-19 were published on December 29, 2020, and subsequently extended. In November 2021, the U.S. Trade Representative determined to extend 81 of the COVID-19 related product exclusions for an additional 6 months. These exclusions are scheduled to expire on May 31, 2022. This notice announces the U.S. Trade Representative's determination to further extend the 81 COVID exclusions for an additional 6 months.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/06/03/2022-11884/notice-of-product-exclusion-extensions-chinas-acts-policies-and-practices-related-to-technology)
- API: https://www.federalregister.gov/api/v1/documents/2022-11884

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
